The Company’s neurodegenerative clinical program remains on track, with continued advancement of the Alzheimer’s Phase 2 trial and anticipation of Parkinson’s Phase 1/2a trial initiation. NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the American Academy of Neurology Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
Regular searches in the ICTRP portal for studies on non-drug interventions are important, but searches for drug studies offer little added value there. This is shown by an IQWiG analysis.
Researchers from Nanyang Technological University, Singapore (NTU Singapore), have created a method that extracts over 80 per cent of the available protein in grain leftovers from brewing beer, commonly known as brewers’ spent grain. Brewers’ spent grain (BSG) is the solid residue from malted barley after brewing beer. It is the most significant byproduct of the beer brewing industry, making up 85 per cent of the total waste. Globally, about 36.4 million tons of spent grain are produced every year. The proteins extracted by the NTU researchers were found to be rich in antioxidants, which could not only protect human skin from pollutants but could also extend the shelf life of cosmetics like body lotions and moisturisers. This could present an eco-friendly alternative to conventional cosmetic components such as parabens, which disrupt hormone function in aquatic organisms, and petroleum-based ingredients,…
Le Commissariat à l’énergie atomique et aux énergies alternatives (CEA) a révélé les images du cerveau obtenues grâce au scanner IRM le plus puissant au monde. Ce scanner a été conçu après plus de deux décennies de recherche et développement dans le cadre du projet Iseult. Mis au point en 2021, il est doté d’une […] France: le scanner IRM le plus puissant au monde redéfinit les limites de l’imagerie cérébrale
An artificial brain from the lab may sound like pure science fiction, but a Japanese-French research team has now actually developed a technique to connect lab-grown brain-like tissues. In a study in the journal Nature Communications, they compare their structure to the neural circuits in the human brain. Lab cultivation of brain cells The researchers at the Institute of Industrial Science […] Advances in brain organoids from the lab
Shenzhen, China (ots/PRNewswire) – Kexing Biopharm (688136.SH) recently announced that the Phase III clinical trial for the inhaled solution of human interferon ?1b, developed by its wholly-owned subsidiary Shenzhen Kexing Pharmaceutical Co., Ltd., has completed the enrollment and dosing of the first patient. This drug is used in children for lower respiratory tract infections (pneumonia, bronchiolitis) […] R&D Progress: Kexing Biopharm Enrolls First Patient in Phase III Clinical Trial of Inhaled Spray for Children
The Menarini Foundation, at the forefront of the fight against discrimination in healthcare for the elderly, contributed to the development of the Florence Charter. The Florence Charter, presented at the "Anti-Ageism Alliance" congress held under the auspices of the Italian Society of Gerontology and Geriatrics, the International Association of Gerontology & Geriatrics, and the European Geriatric Medicine Society, is the first global manifesto against ageism in healthcare. The document, drafted by leading global experts, including WHO representatives, and coordinated by Andrea Ungar, Professor of Geriatrics at the University of Florence, published in the journal European Geriatric Medicine, outlines 12 concrete actions to combat age-related biases in healthcare and improve the quality and duration of life for older people.
Beijing and Paris (ots/PRNewswire) – On March 15, Biologics 2024 in London successfully concluded. A total of 650 representatives from the pharmaceutical, biotechnology, and scientific fields, along with over 50 exhibitors, engaged in high-level discussions on the latest innovations in biologics research and development. As a pioneer in DNA/RNA synthesis technology, Tsingke was honored to […] Tsingke Presents Forward-Looking Biologics Solutions at Biologics 2024
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
